BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gong W, Liang Y, Wu X. Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis. Biomed Res Int 2020;2020:4263079. [PMID: 32025519 DOI: 10.1155/2020/4263079] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Hall TJ, Mullen MP, McHugo GP, Killick KE, Ring SC, Berry DP, Correia CN, Browne JA, Gordon SV, MacHugh DE. Integrative genomics of the mammalian alveolar macrophage response to intracellular mycobacteria. BMC Genomics 2021;22:343. [PMID: 33980141 DOI: 10.1186/s12864-021-07643-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Motiee M, Zavaran Hosseini A, Soudi S. Evaluating the effects of Cyclosporine A immunosuppression on Mycobacterial infection by inhaling of Cyclosporine A administrated BALB/c mice with live Bacillus Calmette Guérin. Tuberculosis (Edinb) 2021;132:102163. [PMID: 34999486 DOI: 10.1016/j.tube.2021.102163] [Reference Citation Analysis]
3 Gong W, Liang Y, Mi J, Jia Z, Xue Y, Wang J, Wang L, Zhou Y, Sun S, Wu X. Peptides-Based Vaccine MP3RT Induced Protective Immunity Against Mycobacterium Tuberculosis Infection in a Humanized Mouse Model. Front Immunol 2021;12:666290. [PMID: 33981313 DOI: 10.3389/fimmu.2021.666290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Rampacci E, Stefanetti V, Passamonti F, Henao-Tamayo M. Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research. Pathogens 2020;9:E641. [PMID: 32781698 DOI: 10.3390/pathogens9080641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Contreras-Magallanes YG, Durán-Aguilar M, Sosa-Gallegos SL, Álvarez ÁH, Andrade-Santillán FA, Bárcenas-Reyes I, González-Ruíz S, Rodríguez-Hernández E, Cantó-Alarcón GJ, Milián-Suazo F. Prime Vaccination with Chitosan-Coated Phipps BCG and Boosting with CFP-PLGA against Tuberculosis in a Goat Model. Animals (Basel) 2021;11:1046. [PMID: 33917739 DOI: 10.3390/ani11041046] [Reference Citation Analysis]
6 Wang Y, Li Z, Wu S, Fleming J, Li C, Zhu G, Chen B, Ren B, Wang X, Du B, Li P, Hu P, Yang J, Liu Y, Zhou C, Zhang XE, Bi L, Zhang H, Yang J, Zhang Z. Systematic Evaluation of Mycobacterium tuberculosis Proteins for Antigenic Properties Identifies Rv1485 and Rv1705c as Potential Protective Subunit Vaccine Candidates. Infect Immun 2021;89:e00585-20. [PMID: 33318140 DOI: 10.1128/IAI.00585-20] [Reference Citation Analysis]
7 Saralahti AK, Uusi-Mäkelä MIE, Niskanen MT, Rämet M. Integrating fish models in tuberculosis vaccine development. Dis Model Mech 2020;13:dmm045716. [PMID: 32859577 DOI: 10.1242/dmm.045716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Alvarez AH. Revisiting tuberculosis screening: An insight to complementary diagnosis and prospective molecular approaches for the recognition of the dormant TB infection in human and cattle hosts. Microbiol Res 2021;252:126853. [PMID: 34536677 DOI: 10.1016/j.micres.2021.126853] [Reference Citation Analysis]
9 Gong W, Liang Y, Mi J, Xue Y, Wang J, Wang L, Zhou Y, Sun S, Wu X. A peptide-based vaccine ACP derived from antigens of Mycobacterium tuberculosis induced Th1 response but failed to enhance the protective efficacy of BCG in mice. Indian Journal of Tuberculosis 2021. [DOI: 10.1016/j.ijtb.2021.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Fatma F, Tripathi DK, Srivastava M, Srivastava KK, Arora A. Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinb) 2021;127:102054. [PMID: 33550109 DOI: 10.1016/j.tube.2021.102054] [Reference Citation Analysis]